Oligoribonucleotide and ribozyme analogs with terminal 3'--3' and/or 5'--5' linkages

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6420546
SERIAL NO

09059331

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to oligoribonucleotide analogs with terminal 3'--3' and/or 5'--5' internucleotide linkages. This modification stabilizes the molecules altered in this way, including ribozymes, without adversely altering their properties, including, where appropriate, catalytic activities.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI-AVENTIS DEUTSCHLAND GMBH65929 FRANKFURT AM MAIN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Krist, Bernd Ulm, DE 16 270
Ortigao, Flavio Ramalho Ulm, DE 1 10
Rosch, Hannelore Erbach, DE 2 38
Rosch, Rudi Erbach, DE 1 10
Seliger, Heinz Hartmut Elchingen, DE 1 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation